TY - JOUR
T1 - T cell repertoire in tuberculosis
T2 - selective anergy to an immunodominant epitope of the 38‐kDa antigen in patients with active disease
AU - Vordermeier, Hans‐M ‐M
AU - Harris, David P.
AU - Friscia, Giuseppe
AU - Román, Eulogia
AU - Surcel, Heljä‐Marja ‐M
AU - Moreno, Carlos
AU - Pasvol, Geoffrey
AU - Ivanyi, Juraj
PY - 1992/10/1
Y1 - 1992/10/1
N2 - It is generally accepted that both host protection and pathogenic reactions in tuberculosis are mediated by T lymphocytes. However, little is known about the structures and discreet functions of epitopes stimulating the immune response. In this study, proliferative responses of blood T lymphocytes to synthetic peptides derived from the sequence of the 38-kDa antigen from Mycobacterium tuberculosis have been investigated in 41 healthy individuals and in 36 patients with active tuberculosis. Of the healthy purified protein derivative (PPD)-positive donors, 90% responded to a permissively recognized peptide, 38.G (residues 350-359), located at the carboxy terminus of the molecule. Four other permissively recognized epitopes of this molecule (38.A, 38.I, 38.E, 38.K) were stimulatory for more than 50% of healthy PPD-positive individuals. Patients with lymphatic tuberculosis responded to these peptides in a similar manner. In contrast, we observed a selective anergy to stimulation with peptide 38.G in the majority of patients with pulmonary (11% responders) and nonlymphatic extrapulmonary tuberculosis (25% responders). The lack of responsiveness to 38.G was epitope specific since the degree of responsiveness to the other four permissively recognized peptide epitopes was similar for patients and PPD-positive controls. Using the PEPSCAN technology and truncated peptides, the core epitope of 38.G was localized to a peptide 10 amino acids long (HFQPLPPAVV). This minimal structure was capable of inducing a proliferative response in all healthy 38.G responders tested. The mechanisms influencing this epitope-specific anergy in patients could give new insights into the immunopathogenesis of tuberculosis.
AB - It is generally accepted that both host protection and pathogenic reactions in tuberculosis are mediated by T lymphocytes. However, little is known about the structures and discreet functions of epitopes stimulating the immune response. In this study, proliferative responses of blood T lymphocytes to synthetic peptides derived from the sequence of the 38-kDa antigen from Mycobacterium tuberculosis have been investigated in 41 healthy individuals and in 36 patients with active tuberculosis. Of the healthy purified protein derivative (PPD)-positive donors, 90% responded to a permissively recognized peptide, 38.G (residues 350-359), located at the carboxy terminus of the molecule. Four other permissively recognized epitopes of this molecule (38.A, 38.I, 38.E, 38.K) were stimulatory for more than 50% of healthy PPD-positive individuals. Patients with lymphatic tuberculosis responded to these peptides in a similar manner. In contrast, we observed a selective anergy to stimulation with peptide 38.G in the majority of patients with pulmonary (11% responders) and nonlymphatic extrapulmonary tuberculosis (25% responders). The lack of responsiveness to 38.G was epitope specific since the degree of responsiveness to the other four permissively recognized peptide epitopes was similar for patients and PPD-positive controls. Using the PEPSCAN technology and truncated peptides, the core epitope of 38.G was localized to a peptide 10 amino acids long (HFQPLPPAVV). This minimal structure was capable of inducing a proliferative response in all healthy 38.G responders tested. The mechanisms influencing this epitope-specific anergy in patients could give new insights into the immunopathogenesis of tuberculosis.
KW - Amino Acid Sequence
KW - Antigens, Bacterial/immunology
KW - Humans
KW - Immunodominant Epitopes/immunology
KW - Lymphocyte Activation
KW - Molecular Sequence Data
KW - Peptide Fragments/immunology
KW - T-Lymphocytes/immunology
KW - Tuberculosis/immunology
UR - http://www.scopus.com/inward/record.url?scp=0026802996&partnerID=8YFLogxK
U2 - 10.1002/eji.1830221024
DO - 10.1002/eji.1830221024
M3 - Article
C2 - 1396968
AN - SCOPUS:0026802996
SN - 0014-2980
VL - 22
SP - 2631
EP - 2637
JO - European Journal of Immunology
JF - European Journal of Immunology
IS - 10
ER -